» Download Public Reports
9 reports
- Company report
- November 2012
- 22 pages
... Y-y -3.7 13.5 1.2 -17.3 -10.8 -11.6 -7.1 -9.5 -10.0 -1.0 Source: ubist, woori i&s research center daewoong: monthly top-10 outpatient prescription drugs (unit: wbn ...
October 2012
... Is similar to last year, but op grew 3%yoy to krw29.1Bn, which beats market expectations (krw20.9Bn) by a large margin. Even with weak prescription drug earnings following drug price cuts in apr, profitability ...
January 2012
... On domestic prescription drug sales and major players Earnings for some time. We advise investors to pay attention selectively to stocks that are less sensitive to domestic demand and poised to see tangible ...
March 2011
... Than-expected earnings thanks to strong drink product and outpatient prescription drug sales. The processed food unit saw solid sales volume growth for pre-cooked rice, trional sauces, and processed meat products ...
March 2011
... On k-gaap stand-alone; k-ifrs parent basis from 2011 source: company data, hyundai securities fig 2: op to rebound in 2h12 amid full-scale growth of new products, such as prescription drugs and apis ...
March 2011
... Is similar to last year, but op grew 3%yoy to krw29.1Bn, which beats market expectations (krw20.9Bn) by a large margin. Even with weak prescription drug earnings following drug price cuts in apr, profitability ...
March 2011
... In prescription drug sales amid a worsening operating environment; 2) a deteriorated product mix stemming from an increase in licensed-in items; and 3) declines in other operating income, such as r&d support ...
March 2011
... Daewoo securities research figure 1. Growth rate of outpatient prescription drug sales (yoy) figure 2. Sk chemicals p/e band source: kdb daewoo securities research source: kdb daewoo securities ...
November 2008
... Outlook: pharmaceuticals (neutral) prescription drug demand to fall in 2009; market releases of generic drugs ...
